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ABSTRAK
Tujuan: menentukan semua kematian dan kematian spesifik akibat kanker pada pasien kanker kolorektal 
dengan obesitas. Metode: pencarian literatur dilakukan pada Pubmed, Proquest, Ebsco, Scopus, dan Cochrane 
sesuai dengan pertanyaan klinis. Seleksi judul dan abstrak berdasarkan kriteria inklusi dan eksklusif, filter 
dobel, pembacaan jurnal secara penuh menghasilkan satu artikel. Studi ini yang berupa metaanalisis dinilai 
kualitasnya berdasarkan validitas, kepentingan, dan aplikabilitas. Hasil: pasien kanker kolorektal dengan 
obesitas mempunyai risiko relatif untuk mengalami kematian dan kematian spesifik akibat kanker, dibandingkan 
dengan pasien kanker kolorektal tanpa obesitas. Kesimpulan: obesitas berhubungan dengan peningkatan risiko 
dari semua kematian dan kematian spesifik akibat kanker pada pasien kanker kolorektal. Kontrol dari berat 
badan sangat direkomendasikan pada pasien ini melalui kombinasi dari diet, aktivitas fisik, terapi perilaku, 
farmakoterapi, dan bedah. 
Kata kunci: kanker kolorektal, kematian spesifik akibat kanker, obesitas pradiagnosis, semua kematian.
ABSTRACT
Aim: to determine all-cause mortality and cancer-spesific mortality of colorectal cancer patient with 
obesity. Methods: a search was conducted on Pubmed, Proquest, Ebsco, Scopus, and Cochrane based on 
clinical query. The screening of title and abstract using inclusion and exclusion criteria, filtering double, and 
reading full text led to one useful article. This study, which is meta-analysis was critically appraised for its 
validity, importance and applicability. Results: the relative risk of colorectal cancer patient with pre-existing 
obesity having cancer-specific mortality and all-cause mortality is 1.22 (95% CI, 1.003-1.35) and 1.25 CI (95% 
CI, 1.14-1.3) respectively, when compared with non-obese colorectal cancer patient. Conclusion: pre-existing 
obesity is related to increased risk of all-cause mortality and cancer-spesific mortality of in colorectal patient. 
Control of body weight is recommended in this patient through combination of diet, physical activity, behavior 
therapy, pharmacotherapy, and surgery.
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INTRODUCTION
Colorectal cancer is the third most common 
cancer in the world. In Indonesia, age-
standardized incidence rates of colorectal cancer 
are 19.1 for men and 15.6 for women per 100,000 
population. Undeniably, the number of colorectal 
cancer cases is high because Indonesia has more 
than 250 million populations.1
Risk factor of colorectal cancer is 
multifactorial, one of which is obesity.2 In 
Indonesia, prevalence of obesity has increased for 
every age group.3 In addition, obesity as a major 
risk factor, has caused mortality and morbidity 
for degenerative disease such as cardiovascular 
disease, dyslipidemia or type 2 diabetes.4
Although colorectal cancer patients’ survival 
has improved in last decades, little is known 
about the prognostic factors which influence 
survival in colorectal cancer patients.5 The aim 
of this evidence-based case report (EBCR) is 
to critically analyze the impact of pre–exiting 
obesity on both all-cause mortality and cancer-
spesific mortality in colorectal cancer patients.
CLINICAL QUESTION
A-52 years old women admitted to hospital 
with hematochezia since two days prior to 
admission. She also felt pain, cramp, and 
abdominal discomfort during defecation since 
six months ago which are worsen recently. 
There are history of alternating diarrhea and 
constipation since four months ago which leads 
to ten kilograms weight loss in four months. In 
addition, she easily feel tired. Last week, doctor 
has diagnosed her having colorectal cancer.
Patient works as an employee in private 
enterprise for 25 years from 8 AM until 3 PM 
everyday. She has four children and now lives 
with her two children who are still in junior high 
school and senior high school. Her husband 
passed away ten years ago by a car accident.
Patient’s height is 155 centimeters. Patient’s 
weight six months ago was 85 kilograms.
How are all-cause mortality and cancer-
specific mortality of colorectal cancer patient 
with obesity?
METHODS
A search of literatures was done in December 
2nd, 2015 on 5 journal databases including 
Pubmed, Proquest, EBSCO, Scopus, and 
Cochrane using terminology listed on Table 1. 
The results obtained from 5 sites were screened 
by title and abstracts using inclusion and 
exclusion criteria, fitered double, and checked 
for those full text availability. After had read 
full text of those articles, we chose the suitable 
article for the our EBCR. Critical appraising the 
meta-analysis study was done by consesus of all 
authors using guidance for prognosis study from 
Center of Evidence-Based Medicine.
RESULTS
We have 10 articles that are suitable for 
EBCR. After reading the full text, we finally 
obtained one meta-analysis study. The other 
9 articles were already included in this meta-
analaysis study.
Meta-analysis from cohort studies done by 
done by Lee et al (2015).6 The result of critical 
appraisal of the meta-analysis is shown on Table 
2. We conclude that the meta-analysis study is 
valid, important, and relevant to our patient with 
level of evidence 1a.
This meta-analysis study is aimed to 
determine association between pre- and post-
diagnostic body mass index (BMI) with colorectal 
cancer-specific mortality and all-cause mortality. 
It was from Medline and EMBASE database that 
published between 1970 and September 2014.
DISCUSSION
We appraised this meta-analysis for its 
validity, importance, and applicability. Several 
reasons support validity of this study. This study 
addresses focused question, selects paper with 
inclusion criteria, appraises included study, and 
has similarity from study to study.
In addition, we found that this study is 
important. The relative risk of patient with pre-
existing obesity having cancer-specific mortality 
is 1.22 with a confidence interval (CI) of 1.003-
1.35. Meanwhile, relative risk for all-cause 
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mortality is 1.25 with a CI of 1.14-1.36. We can 
conclude that the value is precise.
This result seems biological-plausible. 
Although the mechanism of increased mortality 
in obese patients remain unclear, there are several 
studies which already able to synthesize possible 
mechanisms involved. These mechanisms mainly 
associated with obesity-related hormones, 
growth factors, modulation of energy balance and 
calorie restriction, multiple signaling pathways, 
and inflammatory processes.7 Goodwin et al. also 
elucidated about both direct and indirect effect of 
obesity-associated metabolic and adipose tissue 
changes and their role on cancer’s progression.8 
Considering this significant role of obesity 
in colorectal cancer patients’ prognosis, we 
recommended that in order to minimize the 
consequences of deteriorating prognosis, 
obesity’s management should be applied to all 
individuals with risk factor of colorectal cancer, 
such as family history, smoking, dietary intake 
(low fibre, high intake of red and processed meat), 
and lifestyle.9 According to NHLBI guidelines,10 
there are multiple strategies comprised in the 
effective weight control, including dietary 
therapy, physical activity, behavioral therapy, 
pharmacotherapy, and surgery in addition to 
combination of these strategies.
Figure 1. Flowchart of search strategy
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Table 1. Terminology used in 5 journal databases
Location Terminology Hits Selected
Pubmed
Prognosis/Broad [Filter] AND (colorectal cancer OR colorectal carcinoma OR colon 
cancer OR colon carcinoma OR bowel cancer OR bowel carcinoma OR rectal cancer) 
AND ((pre-existing OR pre diagnosis) AND (body mass index OR BMI OR obesity OR 
obese OR overweight)) AND (mortality OR death OR survival OR over all survival OR 
cancer-specific survival OR disease free survival OR prognosis free survival OR all-cause 
mortality OR cancer-specific mortality)
19 1
ProQuest
(MESH.EXACT("Sigmoid Neoplasms") OR MESH.EXACT("Anal Gland Neoplasms") OR 
MESH.EXACT("Colonic Neoplasms") OR MESH.EXACT("Rectal Neoplasms") OR MESH.
EXACT("Adenomatous Polyposis Coli") OR MESH.EXACT("Gardner Syndrome") OR 
MESH.EXACT("Anus Neoplasms") OR MESH.EXACT("Colorectal Neoplasms, Hereditary 
Nonpolyposis") OR MESH.EXACT("Colorectal Neoplasms")) AND (MESH.EXACT("Body 
Mass Index") OR MESH.EXACT("Anthropometry") OR MESH.EXACT("Body Weights 
and Measures")) AND MESH.EXACT("Mortality")
16 0
EBSCOHost
(colorectal cancer OR colorectal carcinoma OR colon cancer OR colon carcinoma 
OR bowel cancer OR bowel carcinoma OR rectal cancer) AND ((pre-existing OR pre 
diagnosis) AND (body mass index OR BMI OR obesity OR obese OR overweight)) AND 
(mortality OR death OR survival OR over all survival OR cancer-specific survival OR 




TITLE-ABS-KEY (colorectal  cancer  OR  colorectal  carcinoma  OR  colon  cancer 
OR  colon  carcinoma  OR  bowel  cancer  OR  bowel  carcinoma  OR  rectal  cancer) 
AND  TITLE-ABS-KEY (body  mass  INDEX  OR  bmi  OR obesity  OR  obesed  OR 
overweight)  AND  TITLE-ABS-KEY (mortality  OR  death  OR  survival  OR  over  ALL 
survival  OR  cancer-specific  survival  OR  disease  free  survival  OR  prognosis  free 
survival  OR  all-cause mortality  OR  cancer-specific  mortality)  AND  SUBJAREA (mult 
OR  agri  OR  bioc  OR  immu  OR  neur  OR  phar  OR  mult  OR  medi  OR  nurs  OR 
vete  OR  dent  OR  heal)
7 0
Cochrane
(colorectal cancer OR colorectal carcinoma OR colon cancer OR colon carcinoma 
OR bowel cancer OR bowel carcinoma OR rectal cancer) AND ((pre-existing OR pre 
diagnosis) AND (body mass index OR BMI OR obesity OR obese OR overweight)) AND 
(mortality OR death OR survival OR over all survival OR cancer-specific survival OR 
disease free survival OR prognosis free survival OR all-cause mortality OR cancer-
specific mortality)
2 0
Table 2. Critical appraisal of meta-analysis6
Validity
Did the meta-analysis address a focused 
question? Yes
Were the criteria used to select articles for 
inclusion appropriate?
Yes 
Is it likely that important relevant studies were 
missed?
No
Was the validity of the included studies appraised? Yes
Were the assessments of studies reproducible? Yes
Were the results similar from study to study? Yes
Importancy What are the overall results of the meta-analysis? Pre-existing obesity was associated with increased 
colorectal cancer-specific mortality (RR: 1.22, 95% CI: 
1.003–1.35, p<0.01) and all-cause mortality (RR: 1.25, 
95% CI: 1.14–1.36, p<0.01)
How precise were the results? Precise, 95% CI interval for colorectal cancer-specific 
mortality and all-cause mortality is narrow
Applicability Can the results be applied to my patient care? Yes
Were all clinically important outcomes considered? Yes
Are the benefits worth the harm and costs? Yes
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As for our patients, with BMI 35.37 kg/
cm2 before the colorectal cancer diagnosis, the 
strategies recommendation is combination of 
diet, physical activity, behavior therapy, and 
pharmacotherapy. Based on National Institutes of 
Health,10 we have to conduct dietary assessment 
first in order to determine the baseline of eating 
pattern and select the optimal intervention. The 
dietary intake recommended with BMI of 35.37 
kg/cm2 on 52-year old woman with moderate 
activity is 1800 calories/day. Physical activities 
recommended include swimming, jogging, 
dancing, or cycling.
CONCLUSION
Pre-existing obesity is related to increased 
risk of all-cause mortality and cancer-spesific 
mortality of in colorectal patient. Control of body 
weight is recommended in individuals with risk 
factors before diagnosis of colorectal cancer. The 
recommendation of weight control strategies for 
this patient before the colorectal cancer diagnosis 
is combination of diet, physical activity, behavior 
therapy, and pharmacotherapy
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